Viewing StudyNCT00022321



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00022321
Status: UNKNOWN
Last Update Posted: 2013-12-19
First Post: 2001-08-10

Brief Title: Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
Sponsor: Jonsson Comprehensive Cancer Center
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Keywords:
Name View
de novo myelodysplastic syndromes View
refractory anemia View
refractory anemia with ringed sideroblasts View
refractory anemia with excess blasts View
refractory anemia with excess blasts in transformation View